13 okt: Nordea/Deutsche: Sænker anbefalingen til "sælg" - NY
13 okt: Sydbank/SHB: Melder sig i koret af kritikere
13-10-2017 08:50:58

AroCell AB: announces that a distribution agreement has been signed with Pathway Diagnostics Ltd, for distribution of the AroCell TK 210 ELISA test in United Kingdom and Ireland.

Relateret indhold

"We very much look forward to this new collaboration with the England based Pathway Diagnostics for the distribution of our TK 210 ELISA test", states Jan Stålemark, AroCell CEO. "Pathway Diagnostics Ltd is a leading supplier of specialist clinical and research diagnostics in the UK and was established in 1998 to provide high quality in-vitro diagnostic products and instrumentation to clinical, research and industrial laboratories mainly in the UK and Ireland. Pathway Diagnostics are highly focused on the needs of their customers and in providing the highest quality products and service and therefore we consider them as a perfect match for our TK 210 ELISA test."

The TK 210 ELISA test will be commercially available immediately through Pathway Diagnostics in the UK and Irish market.

For additional information:

Jan Stålemark, CEO

AroCell AB (publ)

Tel: +46(0)706926206

info@arocell.com

www.arocell.com

This information is information that AroCell is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through Jan Stålemark, at 08:50 CET on 13 October 2017.

About AroCell

AroCell AB (publ) is a Swedish company that develops standardized modern blood tests to support the prognosis and follow up of cancer patients. AroCell's new technology is based on patented methods to measure (Thymidine Kinase 1 (TK1) protein levels in a blood sample.

The TK 210 ELISA test provide valuable information mainly about the condition of cancer patients. This may help clinicians to optimize treatment strategies and estimate the risk of recurrence of the tumor disease during  monitoring of the disease.

AroCell (AROC) is listed at Nasdaq First North and has about 2,500 shareholders. For more information, please see 

www.arocell.com

. Redeye AB is AroCell's Certified Adviser.

Press Release Distribution UK20171011_final


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: AroCell AB via Globenewswire

Vedhæftet fil: 820271.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Vind: Tyrkiet åbner op bud på 1,2 GW havvind

22-06-2018 12:08:41
Tyrkiet har lanceret landets første budrunde på havvindenergi og har allokeret en kapacitet på 1,2 gigawatt til formålet. Myndighederne har fastlagt et loft for budprisen på 80 dollar per megawatt-time, og interesserede selskaber og konsortier skal senest 23. oktober indlevere deres bud. Støtten vil blive givet i form af en elsalgsaftale for de første 50 terawatt-timer produceret energi, skriver R..

Unibrew/Danske: Kursmålet løftes til 525 kr.

22-06-2018 10:45:53
Royal Unibrews opjustering torsdag eftermiddag har fået Danske Bank til at løfte sit kursmål for bryggeriaktien til 520 kr. fra 475 kr. Anbefalingen er uændret "hold", viser data fra Bloomberg News.Unibrews nye prognose lyder på en omsætning mellem 6,8 og 7 mia. kr., et primært driftsresultat (EBITDA) på 1550 til 1625 mio. kr. og et driftsresultat efter af- og nedskrivninger på 1190 til 1265 mio. ..

Aktier/tendens: Unibrew kan ryge op i forventet rolig markedsåbning

22-06-2018 08:07:28
En opjustering fra Royal Unibrew bliver et af fokuspunkterne i fredagens tidlige danske aktiehandel, som generelt ser ud til at ville være præget af mindre bevægelser. Efter torsdagens danske børslukning, hvor det danske C25-indeks sluttede 0,2 pct. lavere i indeks 1119,14, var der ganske vist et lille fald i de amerikanske aktier på Wall Street. Men fredag morgen er der marginale plusser i handle..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Sagen om den manglende cent og quadrofobi

Relaterede aktiekurser

AroCell AB (publ) 6,460 1,6% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer  |  Cookie- og privatlivspolitik  |  Persondatapolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
23. juni 2018 23:16:40
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180619.1 - EUROWEB7 - 2018-06-23 23:16:40 - 2018-06-23 23:16:40 - 1 - Website: OKAY